相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression of CXCL14 and its anticancer role in breast cancer
Xiao-Li Gu et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Proton therapy for hepatocellular carcinoma
Ted C. Ling et al.
CHINESE JOURNAL OF CANCER RESEARCH (2012)
Interventional Radiological Treatment of Hepatocellular Carcinoma: An Update
Anurag Shrimal et al.
INDIAN JOURNAL OF SURGERY (2012)
An intronic polymorphism rs2237062 in the CXCL14 gene influences HBV-related HCC progression in Chinese population
Xing Gu et al.
MOLECULAR BIOLOGY REPORTS (2012)
Role of Tumor Associated Fibroblasts in Human Liver Regeneration, Cirrhosis, and Cancer
Daniela Cesselli et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2011)
Functional characterization of proximal promoter of gene for human BRAK/CXCL14, a tumor-suppressing chemokine
Reika Komori et al.
BIOMEDICAL RESEARCH-TOKYO (2010)
Epigenetic Mechanisms of Promigratory Chemokine CXCL14 Regulation in Human Prostate Cancer Cells
Eun Young Song et al.
CANCER RESEARCH (2010)
Rb inactivation in cell cycle and cancer The puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase
Sabine Paternot et al.
CELL CYCLE (2010)
Reactive oxygen species (ROS) reduce the expression of BRAK/CXCL14 in human head and neck squamous cell carcinoma cells
Yojiro Maehata et al.
FREE RADICAL RESEARCH (2010)
Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis
M. Tessema et al.
ONCOGENE (2010)
Mitochondrial Dysfunction and Reactive Oxygen Species Imbalance Promote Breast Cancer Cell Motility through a CXCL14-Mediated Mechanism
Helene Pelicano et al.
CANCER RESEARCH (2009)
Hepatocellular carcinoma in the Asia pacific region
Man-Fung Yuen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth
Martin Augsten et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CXCL14 expression and potential function in pancreatic cancer
Moritz N. Wente et al.
CANCER LETTERS (2008)
Tumour-immune cell interactions modulated by chemokines
Karin Joehrer et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Molecular targeted therapies in hepatocellular carcinoma
Josep M. Llovet et al.
HEPATOLOGY (2008)
Chemokines in tumor angiogenesis and metastasis
Seema Singh et al.
CANCER AND METASTASIS REVIEWS (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
From molecular biology to targeted therapies for hepatocellular carcinoma: The future is now
Roberta W. C. Pang et al.
ONCOLOGY (2007)
Cancer CXC chemokine networks and tumour angiogenesis
RM Strieter et al.
EUROPEAN JOURNAL OF CANCER (2006)
The multifaceted roles of chemokines in malignancy
A. Ben-Baruch
CANCER AND METASTASIS REVIEWS (2006)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Modulation of CXCL14 (BRAK) expression in prostate cancer
SR Schwarze et al.
PROSTATE (2005)
Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo
GV Shurin et al.
JOURNAL OF IMMUNOLOGY (2005)
Gene- and immunotherapy for hepatocellular carcinoma
DH Palmer et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells
TD Shellenberger et al.
CANCER RESEARCH (2004)
In human hepatocellular carcinoma in cirrhosis, proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair
L Gramantieri et al.
JOURNAL OF HEPATOLOGY (2003)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma
RTP Poon et al.
ANNALS OF SURGERY (2000)
In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue
MJ Frederick et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR α-chemokine
MA Sleeman et al.
INTERNATIONAL IMMUNOLOGY (2000)
分享论文
